Dr. David R. Penberthy, MD
Radiation Oncology (Radiation Oncology Physician)
- Medicare participating
At a glance
- Years since graduation
- 32
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 379
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Radiation Oncology Physician primary
VA license 0101052951 · PA license MD475884 · TN license 65949 -
Specialist
VA license 0101052951
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Virginia Medical Center Charlottesville, VA
Medical groups
- University of Virginia Physicians Group (1,717 clinicians)
- Thompson Oncology Group (65 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 379
- Services billed
- 1,818
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Ct guidance for insertion of radiation therapy fields | 409 | 73 |
| Calculation of radiation therapy dose | 163 | 30 |
| Radiation treatment management, 5 treatment sessions | 112 | 41 |
| Design and construction of complex radiation treatment device | 95 | 36 |
| Complex radiation therapy planning | 29 | 28 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 26 | 17 |
| New patient office or other outpatient visit, 45-59 minutes | 20 | 20 |
| 3d radiation therapy planning | 18 | 17 |
| High precision radiation therapy planning | 15 | 15 |
| Design and construction of radiation treatment device for high precision radiation therapy | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 3 companies reported 4 payments worth $2,447 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $2,200 |
|---|---|
| Gt Medical Technologies, Inc | $173 |
| Kyowa Kirin, Inc. | $74.24 |
| Consulting Fee | $1,900 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $300 |
| Food and Beverage | $247 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Jan 10, 2025 | Consulting Fee TAGRISSO · Oncology | $1,900 |
| AstraZeneca Pharmaceuticals LP Mar 7, 2025 | Compensation for services other than consulting (speaking, faculty) IMFINZI · Oncology Company’s descriptionSpeaker Fee | $300 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.